Multiple Manufacturers

EVOMELA

Manufacturer:

Multiple Manufacturers

Evomela HCPCS:

J9246

HCPCS Code Descriptor:

Injection, melphalan (evomela), 1 mg

Category:

J Code

Evomela NDCs:

68152-0109-00, 72893-0001-01

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

68152-0109-00

About Evomela:

EVOMELA is an Oncology drug manufactured by Acrotech Biopharma and administered via the Intravenous route of administration. The J Code: J9246 is aligned to the drug EVOMELA.

ACCESS PRICING AND MORE BY REGISTERING

J9246 Added Date:

July 1, 2020

J9246 Effective Date:

July 1, 2020

J9246 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Evomela billing and coding information.
Evomela patient assistance information can be found through Acrotech Patient Access at the URL: https://acrotechpatientaccess.com/
EVOMELA prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for EVOMELA. Please check back in a few weeks.